Monica Montes resumes & CV records
Resumes
Monica Montes
Monica Montes
Monica Cortes Montes
Monica Montes
Monica Montes
Monica Montes
Monica Montes
Monica R Montes, 29White Plains, NY
Monica Montes Phones & Addresses
White Plains, NY
Mentions for Monica R Montes
Publications & IP owners
Us Patents
Fusion Proteins Comprising An Anti-Cd40 Antibody And Hiv Antigenic Peptides
US Patent:
2021022, Jul 22, 2021
Filed:
Mar 25, 2021
Appl. No.:
17/301118
Inventors:
- Dallas TX, US
Jacques F. Banchereau - Montclair NJ, US
Anne-Laure FLAMAR - New York NY, US
Yves Levy - , US
Monica Montes - Dallas TX, US
Jacques F. Banchereau - Montclair NJ, US
Anne-Laure FLAMAR - New York NY, US
Yves Levy - , US
Monica Montes - Dallas TX, US
Assignee:
BAYLOR RESEARCH INSTITUTE - Dallas TX
International Classification:
C07K 16/28
C07K 14/005
A61K 39/385
G01N 33/68
C07K 16/00
C07K 14/005
A61K 39/385
G01N 33/68
C07K 16/00
Abstract:
The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccines and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies.
Antigen Presenting Cell Targeted Vaccines
US Patent:
2018009, Apr 5, 2018
Filed:
Oct 18, 2017
Appl. No.:
15/787425
Inventors:
- Dallas TX, US
Jacques F. Banchereau - Montclair NJ, US
Anne-Laure Flamar - New York NY, US
Yves Levy - Paris, FR
Monica Montes - Dallas TX, US
Jacques F. Banchereau - Montclair NJ, US
Anne-Laure Flamar - New York NY, US
Yves Levy - Paris, FR
Monica Montes - Dallas TX, US
International Classification:
C07K 16/28
G01N 33/68
C07K 14/005
G01N 33/68
C07K 14/005
Abstract:
The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccines and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.